The HALT - PKD trial enrolled volunteers to test whether a combination of commonly used FDA - approved drugs, lisinopril and telmisartan, could
shrink kidney cysts and therefore slow progression of ADPKD, a genetic disorder characterized by growth of fluid - filled cysts in the kidneys.